Medtronic Plc

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE00BTN1Y115
USD
91.34
0.44 (0.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jan'26
Oct'25
Jul'25
Apr'25
Jan'25
Oct'24
Jul'24
Net Sales
9,017.00
8,961.00
8,578.00
8,927.00
8,292.00
8,403.00
7,915.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,017.00
8,961.00
8,578.00
8,927.00
8,292.00
8,403.00
7,915.00
Raw Material Cost
3,624.00
3,544.00
3,463.00
3,706.00
3,208.00
3,369.00
3,203.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
181.00
181.00
176.00
174.00
179.00
209.00
167.00
Selling and Distribution Expenses
2,950.00
2,962.00
2,801.00
2,700.00
2,717.00
2,751.00
2,650.00
Other Expenses
54.10
57.30
55.00
51.00
49.60
48.80
50.90
Total Expenditure (Excl Depreciation)
7,296.00
7,260.00
6,990.00
7,090.00
6,600.00
6,817.00
6,529.00
Operating Profit (PBDIT) excl Other Income
1721
1701
1588
1837
1692
1586
1386
Other Income
156.00
76.00
229.00
543.00
140.00
207.00
228.00
Operating Profit (PBDIT)
2,626.00
2,551.00
2,494.00
2,883.00
2,547.00
2,460.00
2,253.00
Interest
181.00
181.00
176.00
174.00
179.00
209.00
167.00
Exceptional Items
-293.00
-28.00
-268.00
-608.00
-146.00
-18.00
-156.00
Gross Profit (PBDT)
5,393.00
5,417.00
5,115.00
5,221.00
5,084.00
5,034.00
4,712.00
Depreciation
749.00
745.00
748.00
840.00
684.00
675.00
662.00
Profit Before Tax
1,404.00
1,597.00
1,302.00
1,261.00
1,540.00
1,559.00
1,268.00
Tax
254.00
215.00
255.00
199.00
237.00
281.00
220.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,144.00
1,375.00
1,040.00
1,057.00
1,294.00
1,269.00
1,042.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,144.00
1,375.00
1,040.00
1,057.00
1,294.00
1,269.00
1,042.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.00
7.00
7.00
5.00
9.00
9.00
6.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,150.00
1,382.00
1,047.00
1,062.00
1,303.00
1,278.00
1,048.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
48,985.00
48,652.00
47,893.00
48,024.00
49,387.00
48,494.00
47,947.00
Earnings per share (EPS)
0.89
1.07
0.81
0.82
1.01
0.99
0.8
Diluted Earnings per share
0.89
1.07
0.81
0.82
1.01
0.99
0.8
Operating Profit Margin (Excl OI)
19.09%
19.31%
17.68%
16.8%
20.78%
18.78%
17.22%
Gross Profit Margin
23.88%
26.14%
23.9%
23.54%
26.82%
26.59%
24.38%
PAT Margin
12.69%
15.34%
12.12%
11.84%
15.61%
15.1%
13.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jan 2026 is 8.74% vs 2.51% in Jan 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jan 2026 is -11.74% vs -2.54% in Jan 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jan 2026 is 2.62% vs 14.84% in Jan 2025

stock-summary

Interest

YoY Growth in quarter ended Jan 2026 is 1.12% vs -4.79% in Jan 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jan 2026 has fallen from Jan 2025

Compare Quarterly Results Of Medtronic Plc With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
9,017.00
2,866.20
6,150.80
214.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,017.00
2,866.20
6,150.80
214.60%
Raw Material Cost
3,624.00
962.80
2,661.20
276.40%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
181.00
0.00
181.00
Selling and Distribution Expenses
2,950.00
687.10
2,262.90
329.34%
Other Expenses
54.10
35.29
18.81
53.30%
Total Expenditure (Excl Depreciation)
7,296.00
2,002.80
5,293.20
264.29%
Operating Profit (PBDIT) excl Other Income
1,721.00
863.40
857.60
99.33%
Other Income
156.00
70.00
86.00
122.86%
Operating Profit (PBDIT)
2,626.00
1,106.00
1,520.00
137.43%
Interest
181.00
0.00
181.00
Exceptional Items
-293.00
21.30
-314.30
-1,475.59%
Gross Profit (PBDT)
5,393.00
1,903.40
3,489.60
183.34%
Depreciation
749.00
171.70
577.30
336.23%
Profit Before Tax
1,404.00
955.60
448.40
46.92%
Tax
254.00
156.10
97.90
62.72%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,144.00
794.80
349.20
43.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,144.00
794.80
349.20
43.94%
Share in Profit of Associates
0
0
0.00
Minority Interest
6.00
4.70
1.30
27.66%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,150.00
799.50
350.50
43.84%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
48,985.00
17,824.00
31,161.00
174.83%
Earnings per share (EPS)
0.89
2.21
-1.32
-59.73%
Diluted Earnings per share
0.89
2.21
-1.32
-59.73%
Operating Profit Margin (Excl OI)
19.09%
30.15%
0.00
-11.06%
Gross Profit Margin
23.88%
39.33%
0.00
-15.45%
PAT Margin
12.69%
27.73%
0.00
-15.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 901.70 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 0.62% vs 4.46% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 8.74% vs 2.51% in Jan 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 115.00 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is -16.79% vs 32.00% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is -11.74% vs -2.54% in Jan 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 247.00 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is -0.20% vs 9.27% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 2.62% vs 14.84% in Jan 2025

Quarterly - Interest
Interest 18.10 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 0.00% vs 2.84% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 1.12% vs -4.79% in Jan 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.09%
in Jan 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jan 2026 has fallen from Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 has fallen from Jan 2025